News
All the latest news
Study: True Risk for Pancreatic Cancer In Patients With Pancreatic Cysts
August 2, 2016
Clinical Trial: New Immune-Stimulating Drug Can Shrink Pancreatic Tumors
May 11, 2016
Saint Louis University Finds Link Between Acute Pancreatitis and Pancreatic Cancer
May 3, 2016
A 10-Year Study Shows Specific Mouth Bacteria May Significantly Increase The Risk of Pancreatic Cancer
April 21, 2016
TGen Launches Two New Clinical Trials To Shrink Pancreatic Cancer Tumors For Advanced Patients
April 15, 2016
PANCREATIC CANCER COLOR IS PURPLE. SHOULD PURPLE BECOME THE NEW PINK?
February 5, 2016
Study Advances Potential Test To Sort Precancerous Pancreatic Cysts From More Harmless Benign Cysts
December 2, 2015
TGen and Dr. Von Hoff Will Lead International Stand Up To Cancer Dream Team To Tackle Pancreatic Cancer
November 11, 2015
FDA APPROVES “ONIVYDE” THERAPY FOR METASTATIC PANCREATIC CANCER
October 28, 2015
TGen’s Dr. Daniel Von Hoff Receives Top Honor from the Arizona Medical Association
May 26, 2015
Potential Boon For Pancreatic Cancer at Johns Hopkins Medical
May 7, 2015
The Future of Cancer: Closer to a Cure
April 29, 2015
Dr. Daniel Von Hoff Chosen As 2015 Researcher of the Year By AZ Business Magazine
April 11, 2015
Seena Magowitz Foundation Funded The Zebrafish Project To Help Accelerate TGen Research Against Pancreatic Cancer
April 7, 2015
What makes pancreatic cancer so aggressive?
April 2, 2015
TGen study says destroying material that ‘cloaks’ cancer cells could benefit patients
March 10, 2015
Cell powerhouse sequencing technology provides deeper look at inherited disease risk
March 10, 2015
Jai Pausch’s Book Praises Roger Magowitz, Tempur-Pedic For Continued Fight Against Pancreatic Cancer
March 3, 2015
Modified Vitamin D Shows Promise as Treatment for Pancreatic Cancer
February 8, 2015
Mattress Firm Commits $1,000,000
December 14, 2014
Dr. Daniel Von Hoff Wins ASCO Award
November 25, 2014
Blood Test Could Catch Early Pancreatic Cancer
November 25, 2014
Scripps Genomic Medicine Award Given To Dr. Daniel Von Hoff
November 18, 2014
Abraxane (Nab-Paclitaxel) Acts Like a Trojan Horse To Extend Life of Late Stage Pancreatic Cancer Patients
November 15, 2014